Literature DB >> 28101621

[Cardiogenic shock].

J Bauersachs1, A Schäfer2.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 28101621     DOI: 10.1007/s00059-016-4528-z

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


× No keyword cloud information.
  15 in total

1.  Extracorporeal life support in cardiovascular patients with observed refractory in-hospital cardiac arrest is associated with favourable short and long-term outcomes: A propensity-matched analysis.

Authors:  Johannes Blumenstein; Jürgen Leick; Christoph Liebetrau; Joerg Kempfert; Luise Gaede; Sebastian Groß; Marcel Krug; Alexander Berkowitsch; Holger Nef; Andreas Rolf; Matthias Arlt; Thomas Walther; Christian W Hamm; Helge Möllmann
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2016-09-20

2.  2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention.

Authors:  Charanjit S Rihal; Srihari S Naidu; Michael M Givertz; Wilson Y Szeto; James A Burke; Navin K Kapur; Morton Kern; Kirk N Garratt; James A Goldstein; Vivian Dimas; Thomas Tu
Journal:  J Am Coll Cardiol       Date:  2015-04-07       Impact factor: 24.094

3.  Intraaortic balloon support for cardiogenic shock.

Authors:  Holger Thiele; Uwe Zeymer; Karl Werdan
Journal:  N Engl J Med       Date:  2013-01-03       Impact factor: 91.245

4.  Outcomes with invasive vs conservative management of cardiogenic shock complicating acute myocardial infarction.

Authors:  Sripal Bangalore; Navdeep Gupta; Yu Guo; Anuradha Lala; Leora Balsam; Robert O Roswell; Alex Reyentovich; Judith S Hochman
Journal:  Am J Med       Date:  2014-12-30       Impact factor: 4.965

5.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

6.  Potential Candidates for a Structured Canadian ECPR Program for Out-of-Hospital Cardiac Arrest.

Authors:  Brian Grunau; Frank Xavier Scheuermeyer; Dion Stub; Robert H Boone; Joseph Finkler; Sarah Pennington; Sarah Ann Carriere; Anson Cheung; Ruth MacRedmond; Jamil Bashir; Jim Christenson
Journal:  CJEM       Date:  2016-03-04       Impact factor: 2.410

Review 7.  Hemodynamics of Mechanical Circulatory Support.

Authors:  Daniel Burkhoff; Gabriel Sayer; Darshan Doshi; Nir Uriel
Journal:  J Am Coll Cardiol       Date:  2015-12-15       Impact factor: 24.094

8.  Mechanical Pre-Conditioning With Acute Circulatory Support Before Reperfusion Limits Infarct Size in Acute Myocardial Infarction.

Authors:  Navin K Kapur; Xiaoying Qiao; Vikram Paruchuri; Kevin J Morine; Wajih Syed; Sam Dow; Nimish Shah; Natesa Pandian; Richard H Karas
Journal:  JACC Heart Fail       Date:  2015-11       Impact factor: 12.035

9.  The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry.

Authors:  William W O'Neill; Theodore Schreiber; David H W Wohns; Charanjit Rihal; Srihari S Naidu; Andrew B Civitello; Simon R Dixon; Joseph M Massaro; Brijeshwar Maini; E Magnus Ohman
Journal:  J Interv Cardiol       Date:  2013-12-13       Impact factor: 2.279

Review 10.  Cannulation strategies for percutaneous extracorporeal membrane oxygenation in adults.

Authors:  L Christian Napp; Christian Kühn; Marius M Hoeper; Jens Vogel-Claussen; Axel Haverich; Andreas Schäfer; Johann Bauersachs
Journal:  Clin Res Cardiol       Date:  2015-11-25       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.